These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Role of time-of-day of hypertension treatment on the J-shaped relationship between blood pressure and cardiovascular risk. Hermida RC; Ayala DE; Mojón A; Fernández JR Chronobiol Int; 2013 Mar; 30(1-2):328-39. PubMed ID: 23181738 [TBL] [Abstract][Full Text] [Related]
12. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction. Hermida RC; Ayala DE; Fernández JR; Mojón A Chronobiol Int; 2013 Mar; 30(1-2):68-86. PubMed ID: 23181592 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular risk of resistant hypertension: dependence on treatment-time regimen of blood pressure-lowering medications. Ayala DE; Hermida RC; Mojón A; Fernández JR Chronobiol Int; 2013 Mar; 30(1-2):340-52. PubMed ID: 23077973 [TBL] [Abstract][Full Text] [Related]
14. Administration-time differences in effects of hypertension medications on ambulatory blood pressure regulation. Hermida RC; Ayala DE; Fernández JR; Mojón A; Smolensky MH; Fabbian F; Portaluppi F Chronobiol Int; 2013 Mar; 30(1-2):280-314. PubMed ID: 23077971 [TBL] [Abstract][Full Text] [Related]
15. Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing. Hermida RC; Ayala DE; Mojón A; Fontao MJ; Fernández JR Chronobiol Int; 2011 Aug; 28(7):601-10. PubMed ID: 21823969 [TBL] [Abstract][Full Text] [Related]
16. Ambulatory blood pressure monitoring: importance of sampling rate and duration--48 versus 24 hours--on the accurate assessment of cardiovascular risk. Hermida RC; Ayala DE; Fontao MJ; Mojón A; Fernández JR Chronobiol Int; 2013 Mar; 30(1-2):55-67. PubMed ID: 23077972 [TBL] [Abstract][Full Text] [Related]
17. Chronotherapy with valsartan/amlodipine fixed combination: improved blood pressure control of essential hypertension with bedtime dosing. Hermida RC; Ayala DE; Fontao MJ; Mojón A; Fernández JR Chronobiol Int; 2010 Jul; 27(6):1287-303. PubMed ID: 20653455 [TBL] [Abstract][Full Text] [Related]
18. 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals. ; ; ; ; ; Hermida RC; Smolensky MH; Ayala DE; Portaluppi F Chronobiol Int; 2013 Apr; 30(3):355-410. PubMed ID: 23517220 [TBL] [Abstract][Full Text] [Related]
19. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)]. Hermida RC; Smolensky MH; Ayala DE; Portaluppi F; Crespo JJ; Fabbian F; Haus E; Manfredini R; Mojón A; Moyá A; Piñeiro L; Ríos MT; Otero A; Balan H; Fernández JR Clin Investig Arterioscler; 2013; 25(2):74-82. PubMed ID: 23849214 [TBL] [Abstract][Full Text] [Related]
20. Relationship between metabolic syndrome, circadian treatment time, and blood pressure non-dipping profile in essential hypertension. Hermida RC; Chayán L; Ayala DE; Mojón A; Fontao MJ; Fernández JR Chronobiol Int; 2011 Jul; 28(6):509-19. PubMed ID: 21797779 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]